UK: Daily Coronavirus press conference in 10 Downing Street hosted by Alok Sharma MP, Part Seven.

The transcript discusses the progress of clinical trials for a vaccine, highlighting a licensing agreement between Oxford University and AstraZeneca for vaccine commercialization. It outlines plans to produce 30 million doses for the UK by September, with a total of over 100 million doses. The UK will have priority access, and efforts will be made to provide the vaccine to developing countries at low cost. Additionally, the UK government is accelerating the construction of a vaccine manufacturing innovation center in Oxfordshire.

How will the vaccine be made available to developing countries?

What is the purpose of the UK's first Vaccines Manufacturing Innovation Center?